NEX-I, First-In-Class Cancer Immunotherapy Development Company
NEX-I develops innovative drugs with its own way distinguishing from the ordinary methods and challenges to build new standards.
NEX-I values and encourages sustainable business
growth for company and career path of individuals.
NEX-I is an assembly of experts with varying areas
of expertise and believes open and respectful communication fosters individual growth and team cohesion.
NEX-I respects each employee and helps them strike a balance between company work and personal life.